BRC Biotechnology (Shanghai) Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

BRC Biotechnology (Shanghai) Co., Ltd. - overview

Established

2022

Location

Shanghai, -, China

Primary Industry

Biotechnology

About

Established in 2022 and based in Shanghai, China, BRC Biotechnology (Shanghai) Co. , Ltd. operates as a biosecurity testing services provider that provides biosafety testing solutions and related services. The company is headquartered in Shanghai, and passed ISO9001: 2015, CMA, BSL-1 and BSL-2 compliance qualifications.


It has 6000 square meters of testing service platform, business office and training center. Cergentis China and SGS Life Sciences Northeast Asia are the strategic partners of the company. In December 2025, BRC Biotechnology (Shanghai) Co. , Ltd.


closed over CNY 100 million in Series A funding led by new investor Cenova Ventures, with participation from new investor Dalton Venture. The company focuses on developing testing service platform which provides biosafety testing solution services for various drug forms, such as antibody drugs, vaccine products, nucleic acid drugs, stem cell products and cellular gene therapy. The company generates revenue from providing biosecurity testing services.


Current Investors

Legend Capital, Cenova Ventures, Dalton Venture

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biotechnology

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.